Results 41 to 50 of about 41,093 (223)

MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

open access: yesMalaria Journal, 2012
The World Health Organization (WHO) convened a malaria vaccines committee (MALVAC) scientific forum from 20 to 21 February 2012 in Geneva, Switzerland, to review the global malaria vaccine portfolio, to gain consensus on approaches to accelerate second ...
Vannice Kirsten S   +3 more
doaj   +1 more source

Optimal control analysis of hepatocytic-erythrocytic dynamics of Plasmodium falciparum malaria

open access: yesInfectious Disease Modelling, 2022
This paper presents an in-host malaria model subject to anti-malarial drug treatment and malaria vaccine antigens combinations. Pontryagin's Maximum Principle is applied to establish optimal control strategies against infected erythrocytes, infected ...
Titus Okello Orwa   +2 more
doaj   +1 more source

Progress and challenges towards the development of malaria vaccines.

open access: yes, 2007
The promise afforded by attenuated sporozoite vaccines in the 1970s led many researchers to believe that an efficacious malaria vaccine was an attainable medium-term goal.
Tetteh, Kevin KA, Polley, Spencer D
core   +1 more source

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults. [PDF]

open access: yes, 2004
BACKGROUND: Many malaria vaccines are currently in development, although very few have been evaluated for efficacy in the field. Plasmodium falciparum multiple epitope (ME)- thrombospondin-related adhesion protein (TRAP) candidate vaccines are designed ...
Greenwood, Brian M   +55 more
core   +1 more source

Molecular vaccines for malaria [PDF]

open access: yesHuman Vaccines, 2010
The basic premise of vaccination is the triggering of host immune responses leading to the induction of adaptive immunity having sufficient magnitude and duration to provide long term protection. This has been achieved by many licensed vaccines, the majority based on attenuated or inactivated organisms, although often the protective antigens and ...
Joseph T, Bruder   +3 more
openaire   +2 more sources

Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.

open access: yesPLoS ONE, 2011
BackgroundGiven the considerable geographic overlap in the endemic regions for malaria and tuberculosis, it is probable that co-infections with Mycobacterium tuberculosis and Plasmodium species are prevalent.
Marcela Parra   +9 more
doaj   +1 more source

Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection

open access: yesNature Communications, 2018
Plasmodium species produce an ortholog of the cytokine macrophage migration inhibitory factor, PMIF, which modulates the host inflammatory response to malaria.
Alvaro Baeza Garcia   +13 more
doaj   +1 more source

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

open access: yesChemFoodChem, EarlyView.
ABSTRACT Fungal antimicrobial resistance (AMR) is a growing concern for world health caused by an increase in multidrug‐resistant infections, an increase in environmental reservoirs, and the ineffectiveness of current antifungal treatments. Fungal infections continue to be largely excluded from AMR initiatives while causing over 1.6 million deaths ...
Bikash Baral
wiley   +1 more source

Vaccine-induced human monoclonal antibodies to PfRH5 show broadly neutralizing activity against P. falciparum clinical isolates

open access: yesnpj Vaccines
Vaccines to the Plasmodium falciparum reticulocyte binding-like protein homologue 5 (PfRH5) target the blood-stage of the parasite life cycle. PfRH5 has the potential to trigger the production of strain-transcendent antibodies and has proven its efficacy
Laty G. Thiam   +18 more
doaj   +1 more source

The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection

open access: yesFrontiers in Immunology, 2020
The RTS,S/AS01 vaccine provides partial protection against Plasmodium falciparum infection but determinants of protection and/or disease are unclear. Previously, anti-circumsporozoite protein (CSP) antibody titers and blood RNA signatures were associated
Ying Du   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy